MADRID (EUROPA PRESS) .- The #National #Administration of #Medicines, #Food and #Medical #Technology (#Anmat) of #Argentina and the #National #Directorate of #Medicines of #El #Salvador approved the emergency use of the vaccine developed by the pharmaceutical company #AstraZeneca and the #University of #Oxford.
They thus become the second and third country to approve this vaccine candidate, after the #United #Kingdom approved it hours before.
#For the health authorities, the #AstraZeneca vaccine “presents an acceptable benefit-risk balance, allowing to support the granting of the registration and conditional authorization of the product for the requested indication”, he collected.#La #Nacin‘.
#This authorization is valid for one year from this #Wednesday and was issued “under the condition of sale by prescription.”
#In the case of #Argentina, it is the second vaccine against covid-19 that received this approval, after the #Russian #Sputnik V – which only applies to the #Latin #American country and #Belarus for the moment – which has already arrived in the country and is being used in the country. health personnel.
#For its part, the #National #Directorate of #Medicines of #El #Salvador informed through a statement the emergency approval for “the import, distribution and use of the vaccine against covid-19 from the firm #AstraZeneca.”
The government of the president, #Nayib #Bukele, closed a purchase with the pharmacy of two million doses of the vaccine that is scheduled to arrive in the country throughout the first quarter of 2021, as the local newspaper ‘#La #Prensa #Grfica’ recalls .
[ source link ]
https://www.proceso.com.mx/internacional/2020/12/31/argentina-el-salvador-aprueban-el-uso-de-emergencia-de-la-vacuna-de-astrazeneca-255386.html
##Argentina ##Salvador #approve #emergency ##AstraZeneca #vaccine